Brenda Ta
Westmead Hospital, NSW, Australia
- This delegate is presenting an abstract at this event.
Dr Brenda Ta is a final year endocrinology trainee at Westmead Hospital and PhD student at The University of Sydney. Her PhD focuses on safer transition strategies with denosumab.
Presentations this author is a contributor to:
Balancing efficacy and rebound risk: extending denosumab dosing intervals in low-risk patients (#388)
5:30 PM
Brenda Ta
Joint Poster Session